Elsevier

Brain Research

Volume 483, Issue 1, 27 March 1989, Pages 117-122
Brain Research

Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH 23390 binding

https://doi.org/10.1016/0006-8993(89)90041-3Get rights and content

Abstract

Behavioural studies have shown that stimulation of D1 receptors, which is uneffective in normal rats, induced strong hypermotility in rats pretreated with reserpine for 5 days. On this basis, we investigated D1 receptor plasticity using the 5-day treatment with reserpine (1 mg/kg; s.c.) as an experimental model. The function of striatal D1 receptors was determined both in binding studies with [3H]SCH 23390 and by measuring formation of cAMP in response to the selective agonist, SKF 82526. The results indicate that the responsiveness of adenylate cyclase (AC) to D1 receptor stimulation was markedly increased after reserpine administration, while no significant changes were found in [3H]SCH 23390 binding site density. Moreover, formation of cAMP after stimulation of Gs protein with GppNHp was markedly enhanced in dopamine (DA)-depleted rats; the responsiveness of AC to forskolin, which directly stimulates the AC catalytic unit, was not affected by reserpine administration. These data indicate that reserpine-induced D1 receptor up-regulation is apparently mediated by a marked enhancement of the coupling efficiency of Gs protein, suggesting that the D1 behavioral supersensitivity does not correlate with the density of D1 receptors, but is reflected by a selective up-regulation of their transduction mechanisms.

Reference (23)

Cited by (56)

  • 6-OHDA-induced hemiparkinsonism and chronic l-DOPA treatment increase dopamine D1-stimulated [<sup>3</sup>H]-GABA release and [<sup>3</sup>H]-cAMP production in substantia nigra pars reticulata of the rat

    2008, Neuropharmacology
    Citation Excerpt :

    We found that the increased sensitivity to D1 receptor stimulation caused by either denervation or l-DOPA is not associated with increased number of dopamine receptors in the SNr. Thus the effects of these treatments in the SNr are in concordance with prior findings in the striatum, where D1-like receptors number and mRNA appear unchanged or diminished after dopaminergic denervation (Missale et al., 1989; Gerfen et al., 1990; Cai et al., 2002). The implication of the binding studies is that the increased response is caused by increased activity in the signaling pathway that takes place downstream from the receptor agonist binding step.

  • Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion

    2003, Biochemical Pharmacology
    Citation Excerpt :

    Although small variations cannot be excluded (due to the sensitivity of the detection), none of these transcripts appeared significantly altered after 6-hydroxydopamine lesion (not shown). The repeated administration of reserpine (for 5 days) was previously found to deplete striatal dopamine by about 80% [38]. After such treatment, a significant decrease in the mRNA levels was observed for the most abundant RGS species detected in the striatum (Fig. 5).

  • Dopaminergic abnormalities in amygdaloid nuclei in major depression: A postmortem study

    2002, Biological Psychiatry
    Citation Excerpt :

    In the human amygdala, both major classes of receptors, D1-like and D2-like including D3 receptors, are present. The pattern of distribution of DA receptors described in this study is similar to the distribution of D1, D2, and D3 receptors observed by others (Gurevich and Joyce 1999; Murray et al 1994; Ryoo et al 1998). [ 125I]Epidepride binding sites have the characteristics of both D2 and D3 receptors depending on the amygdaloid nuclei, and these sites are unevenly distributed among amygdaloid complex (Murray et al 1994).

View all citing articles on Scopus
View full text